全文获取类型
收费全文 | 4588篇 |
免费 | 61篇 |
国内免费 | 10篇 |
专业分类
电工技术 | 56篇 |
综合类 | 3篇 |
化学工业 | 411篇 |
金属工艺 | 83篇 |
机械仪表 | 167篇 |
建筑科学 | 56篇 |
矿业工程 | 3篇 |
能源动力 | 108篇 |
轻工业 | 83篇 |
水利工程 | 28篇 |
石油天然气 | 8篇 |
无线电 | 510篇 |
一般工业技术 | 491篇 |
冶金工业 | 2111篇 |
原子能技术 | 18篇 |
自动化技术 | 523篇 |
出版年
2023年 | 26篇 |
2022年 | 57篇 |
2021年 | 59篇 |
2020年 | 50篇 |
2019年 | 53篇 |
2018年 | 64篇 |
2017年 | 58篇 |
2016年 | 81篇 |
2015年 | 56篇 |
2014年 | 66篇 |
2013年 | 172篇 |
2012年 | 88篇 |
2011年 | 131篇 |
2010年 | 110篇 |
2009年 | 99篇 |
2008年 | 101篇 |
2007年 | 96篇 |
2006年 | 89篇 |
2005年 | 80篇 |
2004年 | 60篇 |
2003年 | 64篇 |
2002年 | 74篇 |
2001年 | 59篇 |
2000年 | 63篇 |
1999年 | 103篇 |
1998年 | 709篇 |
1997年 | 395篇 |
1996年 | 288篇 |
1995年 | 176篇 |
1994年 | 124篇 |
1993年 | 145篇 |
1992年 | 58篇 |
1991年 | 52篇 |
1990年 | 62篇 |
1989年 | 58篇 |
1988年 | 42篇 |
1987年 | 45篇 |
1986年 | 35篇 |
1985年 | 55篇 |
1984年 | 22篇 |
1983年 | 33篇 |
1982年 | 39篇 |
1981年 | 36篇 |
1980年 | 39篇 |
1979年 | 34篇 |
1978年 | 21篇 |
1977年 | 64篇 |
1976年 | 111篇 |
1975年 | 11篇 |
1973年 | 11篇 |
排序方式: 共有4659条查询结果,搜索用时 140 毫秒
941.
942.
AM Kuzminski EJ Del Giacco RH Allen SP Stabler J Lindenbaum 《Canadian Metallurgical Quarterly》1998,92(4):1191-1198
Because cobalamin deficiency is routinely treated with parenteral cobalamin, we investigated the efficacy of oral therapy. We randomly assigned 38 newly diagnosed cobalamin deficient patients to receive cyanocobalamin as either 1 mg intramuscularly on days 1, 3, 7, 10, 14, 21, 30, 60, and 90 or 2 mg orally on a daily basis for 120 days. Therapeutic effectiveness was evaluated by measuring hematologic and neurologic improvement and changes in serum levels of cobalamin (normal, 200 to 900 pg/mL) methylmalonic acid (normal, 73 to 271 nmol/L), and homocysteine (normal, 5.1 to 13.9 micromol/L). Five patients were subsequently found to have folate deficiency, which left 18 evaluable patients in the oral group and 15 in the parenteral group. Correction of hematologic and neurologic abnormalities was prompt and indistinguishable between the 2 groups. The mean pretreatment values for serum cobalamin, methylmalonic acid, and homocysteine were, respectively, 93 pg/mL, 3,850 nmol/L, and 37. 2 micromol/L in the oral group and 95 pg/mL, 3,630 nmol/L, and 40.0 micromol/L in the parenteral therapy group. After 4 months of therapy, the respective mean values were 1,005 pg/mL, 169 nmol/L, and 10.6 micromol/L in the oral group and 325 pg/mL, 265 nmol/L, and 12.2 micromol/L in the parenteral group. The higher serum cobalamin and lower serum methylmalonic acid levels at 4 months posttreatment in the oral group versus the parenteral group were significant, with P < .0005 and P < .05, respectively. In cobalamin deficiency, 2 mg of cyanocobalamin administered orally on a daily basis was as effective as 1 mg administered intramuscularly on a monthly basis and may be superior. 相似文献
943.
944.
PURPOSE: To investigate the effect of organ function on total and free etoposide pharmacokinetics and hematologic toxicity. PATIENTS AND METHODS: Seventy-two patients who received single-agent intravenous (i.v.) etoposide over 5 or 8 days (total dose, 500 mg/m2) were studied. Pharmacokinetic parameters were derived after analysis of total plasma etoposide by high-performance liquid chromatography (HPLC) with ultraviolet (UV) detection, and etoposide protein binding by ultrafiltration of an etoposide-spiked, pretreatment serum sample, followed by HPLC analysis. Free etoposide area under the concentration-time curve (AUC) was derived from the total AUC and protein binding. RESULTS: Patients with renal impairment (serum creatinine level > 130 mumol/L) had a lower plasma etoposide clearance (13.6 v 18.5 mL/min/m2; P = .016), resulting in an increased total-drug and free-drug AUC (total etoposide AUC 615 v 452 micrograms/mL.hr; P = .016; free etoposide AUC 26.0 v 17.6 micrograms/mL.hr; P = .026) and increased hematologic toxicity (nadir neutrophil count 0.3 v 1.9 x 10(9)/L; P = .005). Patients with albumin levels less than 35 g/L had no change in total etoposide kinetics but had an increase in unbound etoposide (5.2% v 4.1%; P = .01), resulting in an increase in free etoposide AUC (27.5 v 16.5 micrograms/mL.hr; P = .003) and more profound toxicity (nadir neutrophil count 0.6 v 1.9 x 10(9)/L; P = .004). In patients with normal albumin and creatinine, increased toxicity in those older than 65 years was associated with a reduced drug clearance, and in those with increased liver enzymes by a trend toward an increase in free etoposide AUC. CONCLUSION: Increased hematologic toxicity after etoposide in patients with abnormal organ function is mediated by an increase in free etoposide AUC. A reduction in dose is clearly indicated in such patients. 相似文献
945.
946.
947.
Subramanian Iyer Jawahar Jain Debashis Sahoo E. Allen Emerson 《Electronic Notes in Theoretical Computer Science》2006,135(2):31
In this paper, we consider the effect of BDD-based under-approximation on a hybrid approach using BDDs and SAT-BMC for error detection on a computing grid. We experimentally study effect of under-approximation approaches on a non-traditional parallelization of BMC based on state space partitioning. This parallelization is accomplished by executing multiple instances of BMC independently from different seed states, that are selected from the reachable states in different partitions. Such states are spread out across the state space and can potentially be deep. Since all processors work independently of each other, this scheme is suitable for bug hunting using a grid-like network. Our experimental results demonstrate improvement over existing approaches, and we show that the method can effectively utilize a large grid network. 相似文献
948.
S Archer J Hirano JK Diss SP Fraser MB Djamgoz 《Canadian Metallurgical Quarterly》1998,9(9):2049-2056
Early-onset familial Alzheimer's disease (early-onset FAD) has been linked with mutations in the presenilin gene, PS1. Mutations in PS1 may affect the processing/trafficking of b-amyloid precursor-protein (bAPP) and favour the production of toxic amyloid-b fragments that are associated with neural degeneration. This study reports the expression of a PS1-like cDNA in the carp (Cyprinus carpio) retina (the encoded protein shows 76% identity to the human PS1 protein). Carp PS1 mRNA was localized by in situ hybridization to the photoreceptor cell, inner nuclear and ganglion cell layers. Expression of the PS1 gene in the rat retina was also confirmed. The retinal expression of PS1 raises the possibility that PS1 mutations also lead to neural degeneration in the retina. 相似文献
949.
JW Francis J Ren L Warren RH Brown SP Finklestein 《Canadian Metallurgical Quarterly》1997,146(2):435-443
Oxygen-free radicals play a major role in neuronal cell injury following cerebral ischemia/reperfusion. The free-radical scavenging enzyme, Cu/Zn superoxide dismutase (SOD-1), ameliorates various types of brain injury resulting from temporary CNS ischemia. We have compared the cerebroprotective properties of human SOD-1 (hSOD-1) with a novel recombinant SOD-1 hybrid protein, SOD:Tet451, composed of hSOD-1 linked to the neuronal binding fragment of tetanus toxin (TTxC). Following 2 h of temporary middle cerebral artery occlusion, rats infused with equivalent activities of either hSOD-1 or SOD:Tet451 for the initial 3 h of reperfusion showed reductions in cerebral infarct volume of 43 and 57%, respectively, compared to saline-treated controls (P < 0.01). Serum hSOD-1 concentrations in rats receiving SOD:Tet451 were seven-fold higher than those in rats receiving the native enzyme. Animals treated with SOD:Tet451 also demonstrated an extended persistence of hSOD-1 in the bloodstream during drug washout as compared to animals given free enzyme. Immunohistochemical examination of brain sections from an SOD:Tet451-treated ischemic rat showed positive immunoreactivity in the ipsilateral cerebral cortex using either anti-TTxC or anti-human SOD-1 antibodies. Our results document that both hSOD-1 and SOD:Tet451 significantly reduce brain infarct volume in a model of transient focal ischemia/reperfusion in rats. Additionally, our findings suggest that the cerebroprotective effects of SOD-1 may be enhanced by neuronal targeting as seen with the hybrid protein SOD:Tet451. 相似文献
950.